I found the source of the death report. copied from main post so Aussies will see it
"The Coroner’s Court confirmed it was investigating a death related to the use of growth-stimulating peptides (CJC 1295 and ipamorelin) prescribed by a medical practitioner."
I would love to know the sourcing of this, and how well that source was vetted before the doctor prescribed it , and what is thought to have caused the death.
I am still a bit confused as to why I am not seeing much in the way of scientific papers documenting these issues, that article alone has a significant number of serious harms and one death from peptides all occurring locally in Victoria, with a population of 7 million. No way to know numbers of peptide users in that area, tens or maybe even hundreds of thousands? Do you need to look up huge numbers of different local drug adverse reaction reports from different locations to get any idea of how common it is? There is no way accurate risks can be determined, but even a vague order of magnitude risk would be better than no idea. And it is important, if the odds of serious adverse reactions were known , it would enable more rational decisions about peptide use especially for use cases that I would see as non essential. Overall I suspect that GLP drugs from grey sources save more lives than are harmed by them, probably a lot more, but is this true for KLOW or GLOW or CJC 1295 and ipamorelin?
The article it is from is generally pretty alarmist in tone and headlines, but is actually medically sourced information.
Victorians are taking peptides for everything from weight loss and body building to skin improvements. Many end up in hospitals with severe side effects.
www.theage.com.au